08:00 , Jan 15, 2015 |  BC Innovations  |  Distillery Techniques

Bio Markers

TECHNOLOGY: Low-density lipoprotein receptor (LDLR) and apolipoprotein A-V (APOA5) mutations to predict early-onset myocardial infarction (MI) risk SNPsGenetic sequencing studies identified rare mutations in LDLR and APOA5 that could predict risk of early onset MI....
07:00 , May 27, 2010 |  BC Innovations  |  Targets & Mechanisms

The case against triglycerides

Although the harmful effects of certain lipids such as low-density lipoprotein cholesterol on the cardiovascular system are well established, the role of triglycerides in heart disease has been suspected but less clear. Now, a large-scale...
07:00 , May 27, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Coronary artery disease (CAD) Apolipoprotein A-V (APOA5) A study in humans suggests that lowering serum triglycerides could be useful for preventing CAD. Combined analysis...